CIS Insulin Market - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

CIS Insulin Market

Description:

The CIS Insulin Market is expected to reach USD 3,008.5 million by 2020 growing at a CAGR of 15.0%, according to a new study by Grand View Research, Inc. – PowerPoint PPT presentation

Number of Views:6
Slides: 8
Provided by: sara01james

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: CIS Insulin Market


1
CIS Insulin Market Size, Share Trends Analysis
Report and Segment Forecast, 2025 Grand View
Research, Inc
Growing fast food industry in CIS region is
expected to push the insulin market in CIS for
next few years.
The CIS Insulin Market is expected to reach USD
3,008.5 million by 2020 growing at a CAGR of
15.0, according to a new study by Grand View
Research, Inc. The presence of an extensive
pipeline portfolio of products exhibiting higher
efficacies and their subsequent commercialization
over the next six years is expected to serve
this market as a high impact rendering driver.
The introduction of government initiatives aimed
at improving the affordability of insulin via
price reduction, such as the collaboration
between the government of Ukraine and Indar to
reduce the price of insulin by 20 in 2013 is
expected to have positive influence on demand.
Some of the other drivers of this market include
increasing attempts made by manufacturers to
capitalize on the untapped opportunities by
opening new manufacturing units to improve the
supply of insulin and growing incidence rates of
type II diabetes are some of the factors expected
to fuel future market growth. To request a
sample copy or view summary of this report, click
the link below http//www.grandviewresearch.com/i
ndustry-analysis/cis-insulin-market Further key
findings from the study suggest
2
  • Regionally, Russia occupied the largest share of
    the market, accounting for 69.2 of the revenue.
    Its large share is majorly attributed by the
    subsidies that Russian government provides to
    make insulin more affordable for patients.
  • Ukraine is expected to register the fastest CAGR
    of 15.6 during the forecast period due to the
    presence of high untapped opportunities and
    encouraging government initiatives.
  • In addition, Poland is expected to grow at a
    lucrative rate during the forecast period majorly
    owing to the presence of high diabetes
    prevalence coupled with increasing healthcare
    expenditures.
  • Long acting insulin accounted for the largest
    share of the market, at over 39.0 in 2013, owing
    to the higher preference given to long acting
    insulin therapy for diabetes which results in
    lesser episodes of low blood sugar. It is also
    expected that this product segment will grow at
    the fastest CAGR of over 18.0 during the next
    six years.
  • Application of insulin for control of type II
    diabetes occupied for over 90.0 of the market
    owing to the presence of larger portfolio of
    products catering to this segment and a
    relatively larger prevalence base
  • Analogs accounted for over 80.0 of the revenue
    owing to their relatively higher prices and
    better efficacy levels. In addition, this
    segment is expected to exhibit the fastest CAGR
    during the forecast period on account of the
    introduction of technologically advanced products
    such as ultra-long and ultra- fast acting
    analogs.
  • Grand View Research has segmented the CIS Insulin
    market on the basis of product, application,
    source and region
  • CIS Insulin Product Outlook
  • Rapid Acting
  • Long Acting

3
  • Short Acting
  • Intermediate Acting
  • CIS Insulin Application Outlook
  • Type II Diabetes
  • Type I Diabetes
  • CIS Insulin Source Outlook
  • Human Recombinant
  • Analogs
  • CIS Insulin Regional Outlook
  • Russia

4
  • Table of Content of CIS Insulin Market
  • Chapter 1. Executive Summary
  • 1.1. CIS Insulin Industry Summary and Critical
    Success Factors (CSFs)
  • Chapter 2. CIS Insulin Industry Outlook
  • Market Segmentation
  • Market Size and Growth Prospects
  • CIS Insulin Market Dynamics
  • Market Driver Analysis
  • Market Restraint Analysis
  • Key Opportunities Prioritized
  • Industry Analysis - Porter's
  • CIS Insulin - Company Market Share Analysis
  • CIS Insulin Market PESTEL Analysis, 2012
  • CIS Insulin Pipeline Overview
  • Chapter 3. CIS Insulin Product Outlook, Volume
    (number of units) and Value (USD Million)
    Estimates and Forecasts, 2012 - 2020
  • Rapid Acting Analog
  • Pricing Analysis (Average Selling Price in USD),
    2012 2020
  • Short Acting Insulin

5
  • Million) Estimates and Forecasts, 2012 - 2020
  • Insulin Analogs
  • Insulin Analogs Market Estimates and Forecasts
  • Human Recombinant Insulin
  • Human Recombinant Insulin Market Estimates and
    Forecasts
  • Chapter 5. CIS Insulin Application Outlook(USD
    Million) Estimates and Forecasts, 2012 - 2020
  • Type I and Other Diabetes
  • Type I and Other Diabetes Market Estimates and
    Forecasts
  • Type II Diabetes
  • Type II Diabetes Market Estimates and Forecasts
  • Chapter 6. Insulin Regional Outlook, Volume
    (number of units) and Value (USD Million)
    Estimates and Forecasts, 2012 - 2020
  • Russia
  • Russia Insulin Market, by Products
  • Russia Insulin Market, by Applications (only
    revenue)
  • Russia Insulin Market, by Source
  • Poland
  • Poland Insulin Market, by Products
  • Poland Insulin Market, by Applications (only
    revenue)
  • Poland Insulin Market, by Source

6
  • 6.5.3. Uzbekistan Insulin Market, by Source
  • Belarus
  • Belarus Insulin Market, by Products
  • Belarus Insulin Market, by Applications (only
    revenue)
  • Belarus Insulin Market, by Source
  • Kazakhstan
  • Kazakhstan Insulin Market, by Products
  • Kazakhstan Insulin Market, by Applications (only
    revenue)
  • Kazakhstan Insulin Market, by Source
  • Rest of CIS
  • Rest of CIS Insulin Market, by Products
  • Rest of CIS Insulin Market, by Applications (only
    revenue)
  • Rest of CIS Insulin Market, by Source

7
About Us Grand View Research, Inc. is a U.S.
based market research and consulting company,
registered in the State of California and
headquartered in San Francisco. The company
provides syndicated research reports, customized
research reports, and consulting services. To
help clients make informed business decisions,
the company offers market intelligence studies
ensuring relevant and fact-based research across
a range of industries including technology,
chemicals, materials, healthcare and
energy. Contact Sherry James Corporate Sales
Specialist, USA Grand View Research, Inc Phone
1-415- 349-0058 Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com Blog
https//healthcareforecastreport.blogspot.com/
About PowerShow.com